Similarly, Eribulin and BI 2536 act in concert to trigger apoptosis in a primary, patient-derived ARMS culture, underscoring the clinical relevance of this combination.
Eribulin and BI 2536 cooperate to suppress tumor growth in an in vivo model of RMS.